Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.50 (-0.77%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.37m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Director/PDMR Shareholding

28 Mar 2025 09:29

RNS Number : 6863C
Macfarlane Group PLC
28 March 2025
 

Macfarlane Group PLC

28th March 2025

 

Macfarlane Group PLC

Director / PDMR Shareholding

Macfarlane Group PLC (LON: MACF) announces that on 26th March 2025 the following persons discharging managerial responsibilities ('PDMRs') acquired ordinary shares of 25 pence each in the Company ("Shares") for nil consideration upon the maturity of the 27th March 2023 awards under the Company's 2022 Deferred Bonus Share Plan ("DBSP"), together with details of the subsequent sale of certain shares automatically arranged on their behalf in accordance with the terms of the DBSP to satisfy related income tax and national insurance liabilities:

PDMR

 

Number of Shares acquired for nil cost (including those added for in respect of dividend equivalent)

 

Number of Shares sold to satisfy income tax and national insurance

Number of Shares retained post sale

Total number of Shares held in the Company

% held of Company's issued share capital

Peter Atkinson

 

64,596

29,128

35,468

1,513,456

0.95%

Ivor Gray

 

31,357

15,397

15,960

303,324

0.19%

 

The Company has been informed that today, the Company's employee benefit trust (the "EBT") purchased 44,525 Shares at an average price of 104.50 pence per Share to help satisfy any future exercise of share options. As a result, the EBT now holds 278,640 Shares in the Company which is approximately 0.17% of the Company's issued share capital.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Settlement of award under the Company DBSP acquired for nil consideration.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

64,596 ordinary shares

31,357 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

Nil

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Peter Atkinson

2. Ivor Gray

2

Reason for Notification

a)

Position/status

1. Chief Executive

2. Group Finance Director

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Macfarlane Group PLC

b)

LEI

213800LVRYDERSJAAZ73

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each in Macfarlane Group plc

GB0005518872

b)

Nature of the transaction

Disposals arranged by the Company's employee benefit trust to cover income tax and national insurance liabilities

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 104.50 pence

2. 104.50 pence

 

 

29,128 ordinary shares

15,397 ordinary shares

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

 

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

 

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973, with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high-quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

 o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

 o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 43 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines, supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDXLDDDGUI
Date   Source Headline
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20217:00 amRNSNotice of AGM
6th Apr 20217:00 amRNSAnnual Report 2020
1st Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSDirector/PDMR Shareholding
4th Mar 20214:41 pmRNSSecond Price Monitoring Extn
4th Mar 20214:35 pmRNSPrice Monitoring Extension
4th Mar 20212:40 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAcquisition
25th Feb 20217:00 amRNSFinal Results
16th Feb 20217:00 amRNSNotice of Results
5th Feb 20217:00 amRNSAppointment of Sole Broker
14th Dec 20207:00 amRNSCompany Secretary Change
19th Nov 20207:01 amRNSBoard Changes
19th Nov 20207:00 amRNSTrading Update
5th Oct 20202:38 pmRNSDirector/PDMR Shareholding
15th Sep 202012:06 pmRNSHalf-year Report
2nd Sep 20201:00 pmRNSDirector/PDMR Shareholding
27th Aug 20207:00 amRNSHalf-year Report
6th Jul 20207:00 amRNSTrading Update
25th Jun 202012:08 pmRNSSecond Price Monitoring Extn
25th Jun 202012:03 pmRNSPrice Monitoring Extension
16th Jun 20203:59 pmRNSHolding(s) in Company
18th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20209:30 amRNSChange of Company Secretary
13th May 20209:30 amRNSResult of AGM
12th May 202012:00 pmRNSAGM Statement
5th May 202010:00 amRNSDisclosure of rights attached to equity shares
9th Apr 20204:30 pmRNSNotice of AGM
6th Apr 20207:00 amRNSAnnual Report 2019
30th Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
2nd Mar 202012:08 pmRNSSecond Price Monitoring Extn
2nd Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSAnnual Results 2019
28th Jan 202010:00 amRNSNotice of Results
20th Nov 20197:00 amRNSTrading Update
11th Oct 20191:27 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSTotal Voting Rights
10th Sep 201911:28 amRNSHalf-year Report
2nd Sep 201912:00 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSAcquisition
22nd Aug 20197:00 amRNSHalf-year Report
7th Aug 20198:02 amRNSNotice of Interim results
31st Jul 20197:46 amRNSHolding(s) in Company
31st May 20198:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.